NCT04227535Active, not recruiting
Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Pathogenesis 2
Source: ClinicalTrials.gov · Last updated 28 Apr 2023
Brief summary (registry, in English)
The overall goal of this study is to identify risk and prognosis factors of Interstitial Lung Disease (ILD) in patients with rheumatoid arthritis (RA).
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 509 (actual)
- First submitted
- 15 Jul 2019
- Start date
- 3 Feb 2020
- Primary completion date
- 1 Oct 2027
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT04227535
What you commit to
- Study type: Observational
- Participants enrolled: 509
- From 3 Feb 2020 to the primary completion date, 1 Oct 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- Lack of signed informed consent
- SELECTION OF CONTROLS:
- \- Lack of signed informed consent
Who the study is looking for
- Age ≥18 years
- RA diagnosis according to ACR (classification of rheumatoid arthritis) 1987 and/or ACR/EULAR 2010 criteria, validated by a senior rheumatologist
- ILD diagnosis based on typical High-Resolution Computed-Tomography (HCRT) patterns and pulmonary function tests (PFT), validated by a senior pulmonologist
- Age ≥18 years
- RA diagnosis according to ACR 1987 and/or ACR/EULAR 2010 criteria, validated by a senior rheumatologist
Criteria the registry did not label
- SELECTION OF CASES :
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bichat Hospital Coordinator of this site? Confirm its status | Paris | France | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.